BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15043512)

  • 1. Review article: hepatitis vaccination in patients with chronic liver disease.
    Reiss G; Keeffe EB
    Aliment Pharmacol Ther; 2004 Apr; 19(7):715-27. PubMed ID: 15043512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination.
    Keeffe EB
    Am J Med; 2005 Oct; 118 Suppl 10A():21S-27S. PubMed ID: 16271537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?
    Keeffe EB
    Am J Gastroenterol; 1995 Feb; 90(2):201-5. PubMed ID: 7847285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.
    Vento S; Garofano T; Renzini C; Cainelli F; Casali F; Ghironzi G; Ferraro T; Concia E
    N Engl J Med; 1998 Jan; 338(5):286-90. PubMed ID: 9445408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E virus infection in chronic liver disease causes rapid decompensation.
    Kc S; Mishra AK; Shrestha R
    JNMA J Nepal Med Assoc; 2006; 45(161):212-5. PubMed ID: 17160100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
    Lau DT; Hewlett AT
    Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course.
    Sagnelli E; Coppola N; Marrocco C; Onofrio M; Sagnelli C; Coviello G; Scolastico C; Filippini P
    J Clin Virol; 2006 Mar; 35(3):317-20. PubMed ID: 16316779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression.
    Lin X; Robinson NJ; Thursz M; Rosenberg DM; Weild A; Pimenta JM; Hall AJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):833-43. PubMed ID: 15946129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection.
    McGovern BH
    Antivir Ther; 2007; 12 Suppl 3():H3-13. PubMed ID: 18284178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of hepatitis vaccination in patients with chronic liver disease.
    Kumar M; Herrera JL
    South Med J; 2010 Dec; 103(12):1223-31. PubMed ID: 21057383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
    Kumar M; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic vaccination in chronic hepatitis B virus carriers.
    Pol S; Michel ML
    Expert Rev Vaccines; 2006 Oct; 5(5):707-16. PubMed ID: 17181443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies.
    Değertekin H; Yalçin K; Yakut M
    Turk J Gastroenterol; 2006 Mar; 17(1):25-34. PubMed ID: 16830274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
    Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.
    Fattovich G; Bortolotti F; Donato F
    J Hepatol; 2008 Feb; 48(2):335-52. PubMed ID: 18096267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B and C: natural course of disease].
    Vince A
    Acta Med Croatica; 2005; 59(5):389-92. PubMed ID: 16381232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.